VRTL vs. BIS
VRTL (GraniteShares 2x Long VRT Daily ETF) and BIS (ProShares UltraShort Nasdaq Biotechnology) are both Leveraged Equities funds. VRTL is actively managed, while BIS is passively managed. Over the past year, VRTL returned 343.57% vs -55.93% for BIS. At a correlation of -0.30, they often move in opposite directions. VRTL charges 1.50%/yr vs 0.95%/yr for BIS.
Performance
VRTL vs. BIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VRTL achieves a 187.83% return, which is significantly higher than BIS's -17.93% return.
VRTL
- 1D
- -22.65%
- 1M
- -11.35%
- YTD
- 187.83%
- 6M
- 172.02%
- 1Y
- 343.57%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BIS
- 1D
- -1.74%
- 1M
- -10.00%
- YTD
- -17.93%
- 6M
- -14.94%
- 1Y
- -55.93%
- 3Y*
- -24.98%
- 5Y*
- -14.70%
- 10Y*
- -26.06%
VRTL vs. BIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
VRTL GraniteShares 2x Long VRT Daily ETF | 187.83% | 110.50% |
BIS ProShares UltraShort Nasdaq Biotechnology | -17.93% | -41.24% |
Correlation
The correlation between VRTL and BIS is -0.27, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.27 |
Correlation (All Time) Calculated using the full available price history since Mar 25, 2025 | -0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VRTL vs. BIS — Risk / Return Rank
VRTL
BIS
VRTL vs. BIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GraniteShares 2x Long VRT Daily ETF (VRTL) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VRTL | BIS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.28 | ||
| Sortino ratioReturn per unit of downside risk | +5.36 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 0.75 | +0.63 |
| Calmar ratioReturn relative to maximum drawdown | 7.30 | -1.02 | +8.31 |
| Martin ratioReturn relative to average drawdown | 17.10 | -1.39 | +18.49 |
Loading charts...
Drawdowns
VRTL vs. BIS - Drawdown Comparison
The maximum VRTL drawdown since its inception was -60.58%, smaller than the maximum BIS drawdown of -99.87%. Use the drawdown chart below to compare losses from any high point for VRTL and BIS.
Loading charts...
Drawdown Indicators
| VRTL | BIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.58% | -99.87% | +39.29% |
Max Drawdown (1Y)Largest decline over 1 year | -47.45% | -55.07% | +7.62% |
Max Drawdown (3Y)Largest decline over 3 years | — | -67.92% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -75.59% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.40% | — |
Current DrawdownCurrent decline from peak | -33.92% | -99.87% | +65.95% |
Average DrawdownAverage peak-to-trough decline | -15.93% | -90.04% | +74.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.20% | 41.32% | -21.12% |
Volatility
VRTL vs. BIS - Volatility Comparison
GraniteShares 2x Long VRT Daily ETF (VRTL) has a higher volatility of 43.78% compared to ProShares UltraShort Nasdaq Biotechnology (BIS) at 13.79%. This indicates that VRTL's price experiences larger fluctuations and is considered to be riskier than BIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VRTL | BIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 43.78% | 13.79% | +29.99% |
Volatility (6M)Calculated over the trailing 6-month period | 92.17% | 32.10% | +60.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 119.83% | 40.51% | +79.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 126.87% | 43.80% | +83.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 126.87% | 46.26% | +80.61% |
VRTL vs. BIS - Expense Ratio Comparison
VRTL has a 1.50% expense ratio, which is higher than BIS's 0.95% expense ratio.
Dividends
VRTL vs. BIS - Dividend Comparison
VRTL has not paid dividends to shareholders, while BIS's dividend yield for the trailing twelve months is around 5.61%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.61% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% |
VRTL GraniteShares 2x Long VRT Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
VRTL and BIS have a correlation of -0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VRTL has higher volatility (43.78%) compared to BIS (13.79%). In terms of maximum drawdown, VRTL dropped -60.58% vs BIS's -99.87%.
On 1-year performance, VRTL leads with 343.57% vs -55.93% for BIS. On fees, BIS is cheaper at 0.95% per year. On volatility, BIS has been the lower-risk option at 13.79%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, VRTL has performed better with a 343.57% return vs -55.93%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BIS is cheaper with a 0.95% expense ratio, compared with 1.50% for VRTL.
BIS has the higher dividend yield at 5.61%, compared with 0.00% for VRTL.
They also come from different issuers: GraniteShares and ProShares. Their fees differ too: 1.50% for VRTL and 0.95% for BIS.
VRTL currently has the higher Sharpe Ratio (2.89 vs -1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VRTL and BIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer